ATE495197T1 - Chimäre konstrukte zwischen auf krebs zielenden peptiden und zellpenetrierenden peptiden gekoppelt an antikrebsmittel und/oder diagnostische mittel - Google Patents
Chimäre konstrukte zwischen auf krebs zielenden peptiden und zellpenetrierenden peptiden gekoppelt an antikrebsmittel und/oder diagnostische mittelInfo
- Publication number
- ATE495197T1 ATE495197T1 AT07716076T AT07716076T ATE495197T1 AT E495197 T1 ATE495197 T1 AT E495197T1 AT 07716076 T AT07716076 T AT 07716076T AT 07716076 T AT07716076 T AT 07716076T AT E495197 T1 ATE495197 T1 AT E495197T1
- Authority
- AT
- Austria
- Prior art keywords
- cell
- seq
- peptides
- cancer
- targing
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 4
- 229940039227 diagnostic agent Drugs 0.000 title abstract 4
- 239000000032 diagnostic agent Substances 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 title abstract 3
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 229940041181 antineoplastic drug Drugs 0.000 abstract 3
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 230000000340 anti-metabolite Effects 0.000 abstract 1
- 229940100197 antimetabolite Drugs 0.000 abstract 1
- 239000002256 antimetabolite Substances 0.000 abstract 1
- 239000003972 antineoplastic antibiotic Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000007850 fluorescent dye Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
- A61K49/0043—Fluorescein, used in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78339606P | 2006-03-20 | 2006-03-20 | |
PCT/SE2007/000268 WO2007108749A1 (en) | 2006-03-20 | 2007-03-20 | Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE495197T1 true ATE495197T1 (de) | 2011-01-15 |
Family
ID=38522712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07716076T ATE495197T1 (de) | 2006-03-20 | 2007-03-20 | Chimäre konstrukte zwischen auf krebs zielenden peptiden und zellpenetrierenden peptiden gekoppelt an antikrebsmittel und/oder diagnostische mittel |
Country Status (5)
Country | Link |
---|---|
US (1) | US20100279918A1 (de) |
EP (1) | EP1991586B1 (de) |
AT (1) | ATE495197T1 (de) |
DE (1) | DE602007011901D1 (de) |
WO (1) | WO2007108749A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9101671B2 (en) | 2007-01-03 | 2015-08-11 | Sanford-Burnham Medical Research Institute | Methods and compositions related to clot binding compounds |
EP2250278B1 (de) * | 2008-02-21 | 2023-04-05 | Burnham Institute for Medical Research | Verfahren und zusammensetzungen in zusammenhang mit peptiden und proteinen mit c-terminalen elementen |
EP2445536B1 (de) | 2009-06-22 | 2016-06-08 | Burnham Institute for Medical Research | Verfahren und zusammensetzungen mit peptiden und proteinen mit c-terminalen elementen |
WO2011020107A2 (en) * | 2009-08-14 | 2011-02-17 | Georgetown University | Compositions and methods for detection and treatment of breast cancer |
EP2512497A1 (de) | 2009-12-18 | 2012-10-24 | Sanford-Burnham Medical Research Institute | Verfahren und zusammensetzungen im zusammenhang mit gerinnselbindenden verbndungen |
CA2800730C (en) * | 2010-05-30 | 2019-06-11 | The Governing Council Of The University Of Toronto | Mitochondrial penetrating peptides as carriers for antimicrobials |
CN103097397B (zh) * | 2010-05-30 | 2015-11-25 | 多伦多大学管理委员会 | 作为抗癌化合物载体的线粒体穿透肽 |
EP2671597A1 (de) * | 2012-06-07 | 2013-12-11 | Cepep III AB | Chimäre Konstrukte zwischen gliomabzielendem Peptid und zellpenetrierenden Peptiden, gHoPe2 |
CN110037999B (zh) | 2012-08-13 | 2023-01-13 | 洛克菲勒大学 | 治疗和诊断黑素瘤 |
CN103981147B (zh) | 2013-02-08 | 2017-11-10 | 中国科学院上海生命科学研究院 | 一种新的制备肝实质细胞的方法 |
WO2014147193A1 (en) * | 2013-03-20 | 2014-09-25 | Centre National De La Recherche Scientifique (Cnrs) | New cell-penetrating peptide motifs |
PL3149025T3 (pl) * | 2014-05-21 | 2019-11-29 | Entrada Therapeutics Inc | Peptydy penetrujące komórkę i sposoby ich wytwarzania i stosowania |
US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
EP3185880B1 (de) | 2014-08-27 | 2020-02-12 | Ohio State Innovation Foundation | Verbesserte peptidyl-calcineurin-hemmer |
US10669311B2 (en) | 2015-04-23 | 2020-06-02 | Sanford Burnham Prebys Medical Discovery Institute | Targeted delivery system and methods of use therefor |
WO2018227112A1 (en) | 2017-06-09 | 2018-12-13 | The Trustees Of Columbia University In The City Of New York | Short tat oligomers for drug delivery |
WO2019104062A1 (en) | 2017-11-21 | 2019-05-31 | Rgenix, Inc. | Polymorphs and uses thereof |
WO2019148194A2 (en) | 2018-01-29 | 2019-08-01 | Ohio State Innovation Foundation | Peptidyl inhibitors of calcineurin-nfat interaction |
TW201945014A (zh) | 2018-02-22 | 2019-12-01 | 美商安卓達治療股份有限公司 | 用於治療粒線體性神經胃腸腦病變之組合物及方法 |
WO2019217682A1 (en) | 2018-05-09 | 2019-11-14 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
CN112386707B (zh) * | 2019-08-19 | 2023-08-11 | 辽宁医学诊疗科技研发中心有限公司 | 一种肿瘤靶向多肽药物偶联物及其制备方法 |
AU2020401286A1 (en) | 2019-12-13 | 2022-06-23 | Inspirna, Inc. | Metal salts and uses thereof |
EP4281034A1 (de) | 2021-01-24 | 2023-11-29 | Forrest, Michael, David | Inhibitoren der atp-synthase kosmetische und therapeutische verwendungen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030077826A1 (en) * | 2001-02-02 | 2003-04-24 | Lena Edelman | Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |
US7488792B2 (en) * | 2002-08-28 | 2009-02-10 | Burnham Institute For Medical Research | Collagen-binding molecules that selectively home to tumor vasculature and methods of using same |
WO2004106370A1 (en) * | 2003-05-28 | 2004-12-09 | Theraptosis Sa | M11l derived peptides and therapeutic use thereof |
WO2004108883A2 (en) * | 2003-06-10 | 2004-12-16 | Toolgen, Inc. | Transducible dna-binding proteins |
EP1968643A2 (de) * | 2005-12-16 | 2008-09-17 | Diatos | Zell-penetrierende peptid-konjugate zur abgabe von nukleinsäuren in eine zelle |
-
2007
- 2007-03-20 AT AT07716076T patent/ATE495197T1/de not_active IP Right Cessation
- 2007-03-20 WO PCT/SE2007/000268 patent/WO2007108749A1/en active Application Filing
- 2007-03-20 EP EP07716076A patent/EP1991586B1/de not_active Not-in-force
- 2007-03-20 US US12/225,367 patent/US20100279918A1/en not_active Abandoned
- 2007-03-20 DE DE602007011901T patent/DE602007011901D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1991586A1 (de) | 2008-11-19 |
WO2007108749A8 (en) | 2009-08-13 |
WO2007108749A1 (en) | 2007-09-27 |
DE602007011901D1 (de) | 2011-02-24 |
EP1991586B1 (de) | 2011-01-12 |
US20100279918A1 (en) | 2010-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE495197T1 (de) | Chimäre konstrukte zwischen auf krebs zielenden peptiden und zellpenetrierenden peptiden gekoppelt an antikrebsmittel und/oder diagnostische mittel | |
PH12014501642B1 (en) | Peptide vaccines for cancers expressing tumor-associated antigens | |
ES2850726T3 (es) | Péptidos de penetración celular para suministro intracelular de moléculas | |
NZ601818A (en) | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers | |
MX2009004147A (es) | Vacunas de peptido para canceres que expresan polipeptidos mphosph1 o depdc1. | |
UA103882C2 (uk) | Композиція пухлино-асоційованих пептидів та відповідна протиракова вакцина | |
Suk Choi et al. | Cell penetrating peptides for tumor targeting | |
UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
Yamaguchi et al. | Identification of cyclic peptides for facilitation of transcellular transport of phages across intestinal epithelium in vitro and in vivo | |
AR067627A1 (es) | Enlazador fmoc polimerico hidrolizable. procedimiento de preparacion | |
US20150119340A1 (en) | Fusion peptide and use thereof for cell membrane penetrating | |
MX2015005867A (es) | Moleculas de transporte especificas de proteoglicano c4s. | |
Biswas et al. | Applications of Peptide in Cancer Therapy | |
US20240092846A1 (en) | Engineered cyclotides with potent broad antimicrobial activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |